These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 6595320

  • 1. [Clinical significance of new tumor marker CA 125 in gynecological cancer--particularly usefulness in diagnosis of ovarian cancer].
    Kimura E, Murae M, Koga R, Odawara Y, Nakabayashi Y, Yokoyama K, Nakata H, Totake T, Ochiai K, Yasuda M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Nov; 36(11):2121-8. PubMed ID: 6595320
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Analysis of CA 125 assay system and its diagnostic significance in gynecologic tumors].
    Shimizu Y, Akagaki E, Hirota K, Kono M, Miura S, Okudaira Y.
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2813-20. PubMed ID: 3866801
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Significance of CA 125 antigen levels in patients with ovarian cancer].
    Shimizu Y, Fujiwara H, Akagaki E, Hirota K, Kono M, Irie T, Miura S, Okudaira Y.
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):46-52. PubMed ID: 3455806
    [Abstract] [Full Text] [Related]

  • 6. [Diagnostic usefulness of stepwise discriminant analysis employing the values of CA125, TPA, IAP, CEA and ferritin in sera measured simultaneously for gynecological malignant neoplasms].
    Yabushita H, Masuda T, Hattori A, Noguchi M, Ito Y, Nakanishi M, Ishihara M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Sep; 37(9):1883-92. PubMed ID: 2997349
    [Abstract] [Full Text] [Related]

  • 7. [Clinical evaluation of specificity of serum CA125 as a tumor marker of ovarian carcinoma].
    Iwasaka T, Ohkuma Y, Yoshimura T, Sugimori H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun; 38(6):917-23. PubMed ID: 2426378
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Studies on CA 125, CA 19-9, TPA and IAP as tumor markers in patients with ovarian cancer].
    Negishi Y, Furuno K, Sano Y, Hirata T, Utsunomiya A, Nakajima H, Okabe K, Shimizu K, Akiya K, Fujiwara Y.
    Gan No Rinsho; 1985 May; 31(6 Suppl):655-63. PubMed ID: 2993692
    [Abstract] [Full Text] [Related]

  • 11. CA54/61 as a marker for epithelial ovarian cancer.
    Nozawa S, Aoki D, Yajima M, Tsukazaki K, Kobayashi T, Kimura E, Terashima Y, Inaba N, Takamizawa H, Negishi Y.
    Cancer Res; 1992 Mar 01; 52(5):1205-9. PubMed ID: 1737381
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Serum CA125 in malignant ovarian tumor--periodical monitoring and correlation with other tumor markers].
    Kawai M, Yamashita H, Hayashi T, Kamiya N, Kakihara M, Arii Y.
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Mar 01; 38(3):402-10. PubMed ID: 3457877
    [Abstract] [Full Text] [Related]

  • 14. [The clinical usefulness of serum CA72-4 analysis in patients with ovarian cancer].
    Kobayashi H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 May 01; 41(5):585-9. PubMed ID: 2754289
    [Abstract] [Full Text] [Related]

  • 15. [Preclinical and clinical studies on a tumor marker, galactosyltransferase associated with tumor (GAT), in ovarian cancer (second report)--clinical significance of GAT and comparison with other tumor markers].
    Nozawa S, Udagawa Y, Ito K, Susumu N, Sasaki H, Aoki D.
    Gan To Kagaku Ryoho; 1993 Feb 01; 20(2):279-85. PubMed ID: 8434967
    [Abstract] [Full Text] [Related]

  • 16. [Studies on clinical usefulness of new tumor markers of ovarian cancer, CA54/61 and CA602--III. Measurement of serum samples from patients with various benign or malignant diseases].
    Nozawa S, Udagawa Y, Sasaki H, Ito K, Akiya K, Terashima Y, Takamizawa H, Ohkura H, Fujimoto S, Hashimoto M.
    Gan To Kagaku Ryoho; 1994 May 01; 21(6):823-32. PubMed ID: 8185340
    [Abstract] [Full Text] [Related]

  • 17. [Clinical significance of the tumor marker CA-125 for the preoperative diagnosis and postoperative management of patients with malignant ovarian cancers].
    Sevelda P, Salzer H, Dittrich C, Spona J.
    Geburtshilfe Frauenheilkd; 1985 Nov 01; 45(11):769-73. PubMed ID: 3865860
    [Abstract] [Full Text] [Related]

  • 18. [Clinical significances of tissue polypeptide antigen in patients with gynecological malignancies].
    Ueda M, Sudo N, Furuya M, Arakawa O, Ikarashi T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Nov 01; 37(11):2361-8. PubMed ID: 3001201
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Application of monoclonal antibody OC 125 in gynecological oncology].
    Wu AR, Wang EY, Wang XX, Jia XH, Li L.
    Zhonghua Zhong Liu Za Zhi; 1988 Mar 01; 10(2):132-6. PubMed ID: 3208653
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.